Table 2.
Overall | p-value | Diabetes Status | Toenail Onychomycosis Severity | |||||||
---|---|---|---|---|---|---|---|---|---|---|
No | Yes | Mild/ Moderate | Severe | |||||||
n=309 | n=149 | n=160 | n=111 | n=188 | ||||||
OR (95% CI) | OR (95% CI) | p-value | OR (95% CI) | p-value | OR (95% CI) | p-value | OR (95% CI) | p-value | ||
Efficacy | ||||||||||
Efficacy* | 1.04 (1.02, 1.05) | <0.01 | 1.01 (0.99, 1.03) | 0.37 | 1.06 (1.04, 1.08) | <0.01 | 1.02 (0.99, 1.05) | 0.13 | 1.05 (1.02, 1.07) | <0.01 |
Treatments | ||||||||||
One pill** | 1.14 (1.04, 1.26) | 0.01 | 1.16 (1.01, 1.34) | 0.03 | 1.12 (0.98, 1.29) | 0.10 | 1.16 (0.99, 1.35) | 0.07 | 1.13 (1.00, 1.28) | 0.05 |
Topical applicator** | 1.15 (1.03, 1.29) | 0.01 | 1.28 (1.09, 1.50) | <0.01 | 1.05 (0.90, 1.23) | 0.55 | 1.12 (0.94, 1.35) | 0.20 | 1.17 (1.02, 1.36) | 0.03 |
Two pills** | 1.03 (0.94, 1.14) | 0.51 | 1.08 (0.94, 1.24) | 0.27 | 0.99 (0.86, 1.14) | 0.88 | 0.93 (0.80, 1.09) | 0.37 | 1.11 (0.98, 1.26) | 0.11 |
Adverse events | ||||||||||
Mild adverse events* | 1.00 (0.99, 1.00) | 0.13 | 1.00 (1.00, 1.00) | 0.80 | 1.00 (0.99, 1.00) | 0.06 | 1.00 (0.99, 1.00) | 0.36 | 1.00 (0.99, 1.00) | 0.22 |
Severe adverse events* | 0.85 (0.80, 0.90) | <0.01 | 0.88 (0.81, 0.95) | <0.01 | 0.82 (0.76, 0.89) | <0.01 | 0.87 (0.79, 0.95) | <0.01 | 0.84 (0.78, 0.90) | <0.01 |
Interactions | ||||||||||
Medication interactions | 0.80 (0.76, 0.85) | <0.01 | 0.86 (0.79, 0.93) | <0.01 | 0.76 (0.70, 0.82) | <0.01 | 0.78 (0.72, 0.86) | <0.01 | 0.82 (0.76, 0.88) | <0.01 |
Alcohol interactions | 0.93 (0.88, 0.98) | 0.01 | 1.04 (0.96, 1.13) | 0.36 | 0.83 (0.77, 0.90) | <0.01 | 0.92 (0.84, 1.01) | 0.08 | 0.93 (0.86, 1.00) | 0.04 |
Notes: *Per 1% increase; **Topical nail lacquer was selected as the reference treatment, ie, the treatment against which other treatments were compared; statistically significant p-values (<0.05) are bold.
Abbreviations: CI, confidence interval; OR, odds ratio.